Status:
RECRUITING
Effectiveness of an App for Tobacco Cessation in Pregnant Women (TOBBGEST)
Lead Sponsor:
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborating Sponsors:
Institut Català de la Salut
Instituto de Salud Carlos III
Conditions:
Pregnant Women
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Background: Tobacco use during pregnancy is one of the most modifiable causes of morbidity and mortality for both pregnant women and their fetus. Despite the fact that smoking among pregnant has decre...
Detailed Description
Design: community-based intervention trial with simple random assignment. Setting and study population: the study population will be drawn from the usual consultations of 4 Sexual and Reproductive He...
Eligibility Criteria
Inclusion
- Pregnant women smokers (report having smoked sporadically or daily in the last 30 days(\*)) over 18 years of age,
- Follow-up of pregnancy in the ASSIR in Camp de Tarragona and Barcelona of the ICS,
- Having a mobile device with Android or iOS operating system and data connection,
- Having skills on the use of Apps and willingness to use them (#).
- (\*) Active smoking is defined as daily or occasional smoking in the last month, regardless of the amount smoked.
- (#) It is understood that you have skills on the use of Apps and willingness to use them if you answer affirmatively to the following questions: Have you downloaded any application on your mobile?, Would you install an application to help you quit smoking on your mobile?, Have you participated in any chat group?, and Have you played any game with your mobile device? (criteria to ensure the usability of the intervention tool).
Exclusion
- Having participated in a smoking cessation study within the last 12 months,
- Psychiatric history that prevents or limits follow-up of the study,
- Inability to follow up for any reason,
- Express refusal of the patient to continue in the study.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05222958
Start Date
February 1 2023
End Date
May 30 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IDIAP Jordi Gol
Barcelona, Barcelona, Spain, 08007